Medicine
Updates on Meningococcal Disease Outbreaks in College Campuses
Quick fact
Meningococcal disease outbreaks on college campuses are rare, but when they occur, they can be deadly: up to 15% of cases are fatal, and survivors often suffer lifelong disabilities. In 2013, an outbreak at Princeton University caused by serogroup B led to a mass vaccination campaign with an unlicensed-in-the-US vaccine to stop the spread.
Why this is interesting
Imagine a campus where a single student's infection triggers a public health emergency. How does a rare disease suddenly become an outbreak among healthy college students?
Read the full explanation
Understanding Updates on Meningococcal Disease Outbreaks in College Campuses
Meningococcal disease is caused by the bacterium Neisseria meningitidis, which can cause meningitis (inflammation of the brain's lining) and septicemia (blood infection). While the bacteria are not easily spread—only through close contact with respiratory or throat secretions—college campuses provide an ideal environment for transmission. Students often live in dormitories, share drinks, smoke, kiss, or spend hours in crowded bars. These behaviors increase the chance of transmitting the bacteria. An outbreak occurs when more cases appear than expected in a short time. Health officials monitor cases and, when two or more cases of the same serogroup occur in a specific population, they declare an outbreak and take action. The main action is vaccination: if the outbreak is caused by a serogroup covered by an available vaccine, they vaccinate all at-risk students, even those previously vaccinated if the vaccine is serogroup-specific. For serogroup B outbreaks, where the routine vaccine was not widely used, emergency use of newer vaccines may be needed.
A deeper explanation
The underlying principle is that N. meningitidis is a commensal bacterium, meaning it can live harmlessly in the nose and throat of healthy carriers (about 10% of people). Carriage rates peak in adolescents and young adults, exactly the age group of college students. Most infected people never show symptoms, but a few will develop invasive disease when the bacterium enters the bloodstream and crosses the blood-brain barrier. The bacterium's outer capsule protects it from immune cells and allows it to survive in the blood. The immune system must produce antibodies that recognize the capsule to clear it, but this takes time. Meanwhile, the bacterium multiplies rapidly, causing severe inflammation and sepsis. Outbreaks occur because the same serogroup (e.g., B) is circulating in a population with low immunity, and the high carriage rate increases the probability of transmission to susceptible individuals. Control measures include prophylactic antibiotics for close contacts (chemoprophylaxis) to eliminate the bacteria, and mass vaccination to reduce carriage and induce herd immunity. The recent emergence of serogroup B outbreaks (e.g., Princeton, Rutgers) prompted the CDC to recommend routine meningococcal B vaccination for all adolescents, highlighting how outbreak responses can lead to policy changes.